The global synthetic biology market was valued at $3,933.9 million in 2014, and it is expected to grow with a CAGR of 35.4% during the period 2015 – 2020. The global synthetic biology market is growing, due to increasing support from government organizations, and growing geriatric population. In addition, the innovative and advanced applications of synthetic biology, increasing research activities, and increasing R&D investments in drug discovery and development are also supporting the growth of this market.
Explore More About “Global Synthetic Biology Market” at: https://www.psmarketresearch.com/market-analysis/synthetic-biology-market
On the basis of type of segment, the technology segment is expected to be the largest market and would witness fastest growth during the forecast period. Among the application segment, pharmaceutical and diagnostic had the largest market size in the global market in 2014.
The information and data in the publication “Global Synthetic Biology Market Size, Share, Development, Growth and Demand Forecast to 2020 – Industry Insights by Enabling Technology (Gene Synthesis, Bioinformatics, Genome Engineering, Cloning, Mutagenesis, Gene Measurement & Modeling, Microfluidics, and Others); by Enabled Technology (Pathway Engineering, and Next-Generation Sequencing); By Tool (Oligonucleotides, Cloning Kits, Enzymes, Xeno Nucleic Acid, Chassis Organisms, and Others), By Application (Pharmaceutical & Diagnostics, Chemical, Energy, Agriculture, and Others)” represent the research and analysis of data from various primary and secondary sources. The top-down approach has been used to calculate the global synthetic biology market size by segment, and application. The market numbers for countries are obtained through top-down approach. P&S Market Research analysts and consultants interacted with the authorities from leading companies of the concerned domain, to substantiate every value of data presented in this report. The company bases its primary research on discussions with prominent professionals and analysts in the industry, which is followed by informed and detailed, online and offline research.
Pre-Purchase Enquiry at: https://www.psmarketresearch.com/send-enquiry?enquiry-url=synthetic-biology-marketGeographically, North America dominated the global market, among all the regions in 2014; and it is expected to grow with a CAGR of 35.2% during the period 2015 – 2020. However, the Asian market is expected to witness fastest growth, with a CAGR of 39.8% during the forecast period.
Get More Information Visit: P&S Market Research
The key companies operating in the global synthetic biology market include E. I. du PONT de Nemours and Company, Amyris Inc., GenScript USA Inc., Intrexon Corporation, Thermo Fisher Scientific Inc., Synthetic Genomics Inc., Royal DSM, Novozymes A/S, New England Biolabs Inc., and Integrated DNA Technologies Inc.
SYNTHETIC BIOLOGY MARKET SEGMENTATION
Breakdown by Segment
- Enabling Technology
- Gene Synthesis
- Genome Engineering
- Gene Measurement and Modeling
- Enabled Technology
- Pathway Engineering
- Next Generation Sequencing
- Enabling Technology
- Cloning Kit
- Xeno Nucleic Acid
- Chassis Organisms
Breakdown by Application
- Pharmaceutical and R&D
Breakdown by Geography
- North America – The U.S., Canada, and Rest of North America
- Europe – the U.K., Germany, France, Italy, Spain, and Rest of Europe
- Asia – China, Japan, India, and Rest of Asia
- Rest of the World (RoW)